We are live on ! Find out more
FBIO icon

Fortress Biotech

48 hedge funds and large institutions have $13.3M invested in Fortress Biotech in 2023 Q2 according to their latest regulatory filings, with 5 funds opening new positions, 11 increasing their positions, 14 reducing their positions, and 11 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,500% more call options, than puts

Call options by funds: $32K | Put options by funds: $2K

0.53% less ownership

Funds ownership: 1.73%1.2% (-0.53%)

11% less funds holding

Funds holding: 5448 (-6)

21% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 14

43% less capital invested

Capital invested by funds: $23.4M → $13.3M (-$10.1M)

55% less first-time investments, than exits

New positions opened: 5 | Existing positions closed: 11

Holders
48
Holders Change
-6
Holders Change %
-11.11%
% of All Funds
0.75%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
5
Increased
11
Reduced
14
Closed
11
Calls
$32K
Puts
$2K
Net Calls
+$30K
Net Calls Change
+$18K
Name Holding Trade Value Shares
Change
Change in
Stake
Two Sigma Advisers
51
Two Sigma Advisers
New York
-$21.2K -1,727 Closed
LPL Financial
52
LPL Financial
California
-$16.4K -1,333 Closed
VF
53
Virtu Financial
New York
-$11K -881 Closed
SAG
54
Spotlight Asset Group
Illinois
-$7K -713 Closed
EIM
55
Essex Investment Management
Massachusetts
-$4.67K -380 Closed
First Manhattan
56
First Manhattan
New York
-$2.09K -170 Closed
WFA
57
West Financial Advisors
Iowa
-$820 -67 Closed
OLVIG
58
Oliver Lagore Vanvalin Investment Group
Michigan
-$328 -27 Closed
Royal Bank of Canada
59
Royal Bank of Canada
Ontario, Canada
+$307 +31 New

FBIO Hedge Fund Activity: Q2 2023 in Review

48 of the 6,369 institutional investors tracked by Wall St. Rank reported a position in Fortress Biotech (FBIO) for Q2 2023, worth a combined $13.3M — down 43% from $23.4M a quarter earlier.

Sellers outnumbered buyers: 11 funds closed out of FBIO and 5 opened new positions — a net loss of 6 holders — while 14 trimmed existing stakes and 11 added.

The largest buyer was 1900 Wealth Management, adding an estimated $183K. The largest seller was Jefferies Financial Group, exiting entirely with an estimated $2.34M sold.

  • 48 institutional investors held Fortress Biotech (FBIO) as of Q2 2023, down from 54 in Q1 2023.
  • Funds reported $13.3M of Fortress Biotech stock for Q2 2023, down 43% quarter-over-quarter.
  • 5 funds opened new Fortress Biotech positions in Q2 2023 and 11 closed out, a net change of -6 holders.
  • The largest Fortress Biotech buyer in Q2 2023 was 1900 Wealth Management, an estimated $183K added.
  • The largest Fortress Biotech seller in Q2 2023 was Jefferies Financial Group, an estimated $2.34M sold.

Based on aggregated 13F filings for Q2 2023.